Biotricity, Inc. · OTC:BTCY

Biotricity — Investor Presentation (October 2023)

20 slides from Biotricity's investor presentation, October 2023

  1. Slide 1: The Future of Cardiac Outpatient Monitoring

    The Future of Cardiac Outpatient Monitoring NASDAQ - BTCY CARDIAC OUTPATIENT THE FUTURE OF REAL-TIME OUTPATIENTMONITORING MONITORING OCTOBER APRIL 2023

  2. Slide 2: Important Cautions Regarding Forward Looking Statements

    Important Cautions Regarding Forward Looking Statements: Certain information contained in this presentation includes “forward-looking statements.” Statements which are not historical reflect our current expectations and projections about our future results, performance, liquidity, financial conditio

  3. Slide 3: Biotricity – Corporate Summary

    Biotricity – Corporate Summary • Improving quality of care and saving lives with a revolutionary product portfolio and business model, targeting a multi-Billion-dollar TAM 3, 4 • Selling proprietary FDA approved cardiac monitoring solution today across 34 states utilizing it daily with new sites/car

  4. Slide 4: Biotricity Growth Strategy and Recent Highlights

    Biotricity Growth Strategy and Recent Highlights • Expansion into IDNs, GPOs • Channel Expansions through Strategic Partners/Distributors • 2024 – full commercial rollout of new products • Vertical strategy aligned with our horizontal strategy (network expansion), selling into the existing channel •

  5. Slide 5: Problem: Cardiac Care

    Problem: Cardiac Care • Cardiac Care is disjointed with different solutions from different vendors • Cardiac issues are intermittent, and patients are often asymptomatic, requiring long-term data with connectivity • Most solutions are passive, i.e. do not upload data throughout the study $96.67B • P

  6. Slide 6: Cardiac Patient Journey – Biotricity Viewpoint

    Cardiac Patient Journey – Biotricity Viewpoint DIGITAL HEALTH MEDICAL TECH DIGITAL HEALTH DIAGNOSIS TESTS INTERVENTIONS COACHING CARDIAC MONITORING PROCEDURES FOLLOW-UP PRE-DIAGNOSIS PATIENT VISIT CONTINUOUS (AT-RISK) PRESCRIPTIONS MANAGEMENT THE FUTURE OF CARDIAC OUTPATIENT MONITORING OCTOBER 2023

  7. Slide 7: Total Addressable Market

    Total Addressable Market ACTIVE CARDIAC CONNECTED CARDIC DISEASE CONTINUOUS HEART REMOTE PATIENT MONITORING MONITORING MANAGEMENT MONITORING MONITORING Chronic Cardiac Care Cardiac Outpatient Monitoring Holter and Extended Holter Cardiac Lifestyle Management Remote Patient Monitoring Management (COM

  8. Slide 8: Biotricity Competitive Differentiators

    Biotricity Competitive Differentiators DISRUPTIVE NETWORK DISRUPTIVE BUSINESS MODEL EFFECT TECHNOLOGY ü Insourced business model, enabling ü Diagnostic brings more data & action ü Turn-key solution: device, software, and physicians to increase profit and bill directly cloud platform ü Complementary

  9. Slide 9: Current Footprint – Bioflux & Biotres

    Current Footprint – Bioflux & Biotres • Portfolio of complementary technologies WA • Bioheart – launched January 2021 MT ND ME • Biotres - FDA cleared January 2022 OR ID MN VT • Biocare Health App – launched January 2023 NH • Biocare Cardiac- launched October 2023 WI NY SD MA WY MI • Biotres Pro – l

  10. Slide 10: Clinical Ecosystem Evidence

    Clinical Ecosystem Evidence Network: 2198 Physicians and Growing Tachy > 150: 152,970,100 beats recorded, annotated, and reviewed by a physician o 98,200 studies expected for next 12 months Brady < 40: 21,483,240 beats recorded, annotated, and reviewed by a physician 178,756 Studies Conducted o 53%

  11. Slide 11: Biocare: Diagnostics/Disease & Lifestyle Management

    DISEASE & LIFESTYLE DIAGNOSTIC TOOLS MANAGEMENT TOOLS SECURE DATA STORAGE PHYSICIAN PORTAL/PATIENT APP Biocare: Diagnostics/Disease & Lifestyle Management

  12. Slide 12: Bioflux

    • Bioflux is a 3-lead for active cardiac monitoring designed for patients who have risk factors for or are diagnosed with certain cardiac issues. • Cellular & GPS enabled complete with Bioflux Software • Bioflux can operate as a Holter, Extended Holter, and COM. • Digital report to inform diagnosis

  13. Slide 13: Biotres

    • Biotres is a 3-lead patch solution for passive arrhythmia monitoring designed for patients who have risk factors for, or are diagnosed with certain cardiac issues • Biotres can operate as a Holter, Extended Holter, and MCT. • Now cleared, Biotres will ensure advanced capability while focusing on e

  14. Slide 14: Bioheart: 3 Lead Heart Rhythm – No Prescription

    3 Lead Heart Rhythm – No Prescription • Continuous data collection allows for unparalleled accuracy on par with prescription-grade devices • Data syncs to Bioheart's app delivering personalized insights for lifestyle management • Integrated with disease management platform to give the individual hol

  15. Slide 15: Biocare virtual clinic platform

    + Biocare is a HIPAA-compliant virtual clinic and disease management platform designed to meet cardiologists' needs for patient management. Ensures a seamless integration into any clinic’s current workflow, saving time, and reducing costs Key features Include: • Book & Manage • Connected Diagnostic

  16. Slide 16: Product Platform

    Product Platform Vertical and Horizontal Strategy ACTIVE CARDIAC CONNECTED CARDIC DISEASE CONTINUOUS HEART REMOTE PATIENT MONITORING MONITORING MANAGEMENT MONITORING MONITORING Chronic Cardiac Care Cardiac Outpatient Monitoring Holter and Extended Holter Cardiac Lifestyle Management Remote Patient M

  17. Slide 17: THE FUTURE OF CARDIAC OUTPATIENT MONITORING OCTOBER 2023

    THE FUTURE OF CARDIAC OUTPATIENT MONITORING OCTOBER 2023

  18. Slide 18: Disjointed Care & Multiple Workflows

    Disjointed Care & Multiple Workflows: Nurses are multiplexing through many systems Diagnostics | CCM | EMR | ILR | Telemedicine | RPM CLINIC ECOSYSTEM CLINIC ECOSYSTEM WITHOUT BIOTRICITY WITH BIOTRICITY Biocare Diagnostics ü Diagnostics RPM Vendor ü RPM CCM Vendor ü CCM ILR Vendor ü ILR Telemed Vend

  19. Slide 19: Proven Team

    Proven Team OPERATIONS MANAGEMENT SALES Over 50 years of collective Over 100 years of collective startup Over 150 years of collective experience with leading experience experience launching new medical organizations Proven record of raising over devices from over 15 startups, all in $100m capital ac

  20. Slide 20: Redefining Healthcare to work for you

    Redefining Healthcare to work for you THE FUTURE OF REAL-TIME OUTPATIENT MONITORING APRIL 2023

Biotricity — Investor Presentation (October 2023) on 6ix